Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Chia Yu

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Oncotarget|March 3, 2016
Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expressionYu-Chao Chang, Cheng-Wei Lin, Cheng-Chia Yu, et al.
Environmental Toxicology|January 13, 2018
Hinokitiol ablates myofibroblast activation in precancerous oral submucous fibrosis by targeting SnailHui-Wen Yang, Ming-Yi Lu, Yu-Wei Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 13, 2022
Fenofibrate diminishes the self-renewal and metastasis potentials of oral carcinoma stem cells through NF-κB signalingTzu-Rong Su, Cheng-Chia Yu, Shih-Chi Chao, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Synergistic Effect of Combination of a Temoporfin-Based Photodynamic Therapy with Potassium Iodide or Antibacterial Agents on Oral Disease Pathogens In VitroYin-Hwa Shih, Cheng-Chia Yu, Kai-Chi Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 9, 2021
Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblastsJyun-Yang Su, Cheng-Chia Yu, Chih-Yu Peng, et al.
Journal of Cellular and Molecular Medicine|September 25, 2024
Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR-20a-5p-mediated pyroptosisCheng-Chia Yu, Pei-Ling Hsieh, Shih-Chi Chao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 1, 2018
miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblastsMing-Yi Lu, Cheng-Chia Yu, Pei-Yin Chen, et al.
Oncotarget|June 7, 2018
Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cellsChe-Yi Lin, Pei-Ling Hsieh, Yi-Wen Liao, et al.
Journal of Dental Sciences|July 14, 2025
GAS5 decreased the arecoline-induced myofibroblasts activity in buccal mucosal fibroblasts via acting as a competing endogenous RNA for miR-21Chuan-Hang Yu, Heng-Yi Liao, Jung-Chun Yeh, et al.
Journal of Dental Sciences|February 2, 2024
Targeting histone deacetylase 9 represses fibrogenic phenotypes in buccal mucosal fibroblasts with arecoline stimulationPo-Yu Yang, Chih-Yuan Fang, Shih-Chi Cho, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Oncotarget|March 3, 2016
Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expressionYu-Chao Chang, Cheng-Wei Lin, Cheng-Chia Yu, et al.
Environmental Toxicology|January 13, 2018
Hinokitiol ablates myofibroblast activation in precancerous oral submucous fibrosis by targeting SnailHui-Wen Yang, Ming-Yi Lu, Yu-Wei Chiu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 13, 2022
Fenofibrate diminishes the self-renewal and metastasis potentials of oral carcinoma stem cells through NF-κB signalingTzu-Rong Su, Cheng-Chia Yu, Shih-Chi Chao, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Synergistic Effect of Combination of a Temoporfin-Based Photodynamic Therapy with Potassium Iodide or Antibacterial Agents on Oral Disease Pathogens In VitroYin-Hwa Shih, Cheng-Chia Yu, Kai-Chi Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 9, 2021
Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblastsJyun-Yang Su, Cheng-Chia Yu, Chih-Yu Peng, et al.
Journal of Cellular and Molecular Medicine|September 25, 2024
Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR-20a-5p-mediated pyroptosisCheng-Chia Yu, Pei-Ling Hsieh, Shih-Chi Chao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 1, 2018
miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblastsMing-Yi Lu, Cheng-Chia Yu, Pei-Yin Chen, et al.
Oncotarget|June 7, 2018
Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cellsChe-Yi Lin, Pei-Ling Hsieh, Yi-Wen Liao, et al.
Journal of Dental Sciences|July 14, 2025
GAS5 decreased the arecoline-induced myofibroblasts activity in buccal mucosal fibroblasts via acting as a competing endogenous RNA for miR-21Chuan-Hang Yu, Heng-Yi Liao, Jung-Chun Yeh, et al.
Journal of Dental Sciences|February 2, 2024
Targeting histone deacetylase 9 represses fibrogenic phenotypes in buccal mucosal fibroblasts with arecoline stimulationPo-Yu Yang, Chih-Yuan Fang, Shih-Chi Cho, et al.
Pageof 18